Skip to main content

Table 2 Univariate analysis of factors associated with overall survival of 187 patients with UCB

From: PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway

Variable

All cases

RR (95% CI)

P valuea

 

Age(years)

  

0.309

 

≤60b

80

1

  

>60

107

1.332 (0.767-2.315)

  

Gender

  

0.648

 

Male

166

1

  

Female

21

0.807 (0.321-2.026)

  

Tumor multiplicity

  

0.676

 

Unifocal

79

1

  

Multifocal

108

1.443 (0.852-2.471)

  

WHO grade

  

0.022

 

G1

46

1

  

G2

66

2.304 (0.968-5.485)

  

G3

75

3.206 (1.396-7.363)

  

pT status

  

<0.001

 

pT1

35

1

  

pT2

95

1.535 (0.890-2.653)

  

pT3

37

3.025 (1.242-7.363)

  

pT4

20

7.457 (2.950-18.847)

  

pN status

  

<0.001

 

pN-

157

1

  

pN+

30

8.904 (5.056-15.681)

  

PinX1

  

<0.001

 

Negative expression

83

5.148 (2.708-9.786)

  

Positive expression

104

1

  
  1. aChi-square test. bmean age. RR: relative risk. CI: confidence interval.
  2. UCB: urothelial carcinoma of bladder.